EyePoint Pharmaceuticals (EYPT) 10-K/A 2020 FY Annual report (amended)

Exhibit 31.4

Certification of Principal Financial Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the Securities Exchange Act of 1934, as amended.

CERTIFICATIONS

I, George O. Elston, certify that:

1. I have reviewed this Amendment No. 1 to the annual report on Form 10-K/A of EyePoint Pharmaceuticals, Inc.; and

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.

Dated May 4, 2021	By:	/s/ George O. Elston
	Name:	George O. Elston
	Title:	Chief Financial Officer
		(Principal Financial Officer and Principal Accounting Officer)